Affiliations
AffiliationsItem in Clipboard
Urban-Rural Disparities in Access to Low-Dose Computed Tomography Lung Cancer Screening in Missouri and IllinoisKarthik W Rohatgi et al. Prev Chronic Dis. 2020.
doi: 10.5888/pcd17.200202. AffiliationsItem in Clipboard
Erratum in[No authors listed] [No authors listed] Prev Chronic Dis. 2022 Apr 7;19:E17. doi: 10.5888/pcd19.200202e. Prev Chronic Dis. 2022. PMID: 35389832 Free PMC article.
Introduction: Low-dose computed tomography (LDCT) lung cancer screening is recommended for current and former smokers who meet eligibility criteria. Few studies have quantitatively examined disparities in access to LDCT screening. The objective of this study was to examine relationships between 1) rurality, sociodemographic characteristics, and access to LDCT lung cancer screening and 2) screening access and lung cancer mortality.
Methods: We used census block group and county-level data from Missouri and Illinois. We defined access to screening as presence of an accredited screening center within 30 miles of residence as of May 2019. We used mixed-effects logistic models for screening access and county-level multiple linear regression models for lung cancer mortality.
Results: Approximately 97.6% of metropolitan residents had access to screening, compared with 41.0% of nonmetropolitan residents. After controlling for sociodemographic characteristics, the odds of having access to screening in rural areas were 17% of the odds in metropolitan areas (95% CI, 12%-26%). We observed no association between screening access and lung cancer mortality. Southeastern Missouri, a rural and impoverished area, had low levels of screening access, high smoking prevalence, and high lung cancer mortality.
Conclusion: Although access to LDCT is lower in rural areas than in urban areas, lung cancer mortality in rural residents is multifactorial and cannot be explained by access alone. Targeted efforts to implement rural LDCT screening could reduce geographic disparities in access, although further research is needed to understand how increased access to screening could affect uptake and rural disparities in lung cancer mortality.
FiguresFigure 1
Measures of rurality in Missouri…
Figure 1
Measures of rurality in Missouri and Illinois and location of low-dose computed tomography…
Figure 1Measures of rurality in Missouri and Illinois and location of low-dose computed tomography screening centers. A, Rural–urban commuting area (RUCA) categories at the census tract level, determined by US Department of Agriculture Economic Research Service (16). B, National Center for Health Statistics (NCHS) rural–urban classification codes at the county level (17). Data on screening centers obtained from American College of Radiology (11) and GO2 Foundation for Lung Cancer (12). Shapefiles obtained from ESRI (20).
Figure 2
Access to LDCT lung cancer…
Figure 2
Access to LDCT lung cancer screening, lung cancer mortality, and smoking prevalence in…
Figure 2Access to LDCT lung cancer screening, lung cancer mortality, and smoking prevalence in Missouri and Illinois. A, Percentage of residents aged 55–79 with access to an LDCT lung cancer screening center within 30 miles. B, Lung cancer mortality (deaths per 100,000) among adults aged ≥60. C, Adult smoking prevalence. All maps are at the county level, and categories are based on rounded quintiles. Data obtained from American College of Radiology (11), GO2 Foundation for Lung Cancer (12), Surveillance, Epidemiology, and End Results program (18), and County Health Rankings (19). Shapefiles from ESRI (20). Abbreviation: LDCT, low-dose computed tomography.
Similar articlesOdahowski CL, Zahnd WE, Eberth JM. Odahowski CL, et al. J Am Coll Radiol. 2019 Apr;16(4 Pt B):590-595. doi: 10.1016/j.jacr.2019.01.001. J Am Coll Radiol. 2019. PMID: 30947892
Sahar L, Douangchai Wills VL, Liu KKA, Fedewa SA, Rosenthal L, Kazerooni EA, Dyer DS, Smith RA. Sahar L, et al. Cancer. 2022 Apr 15;128(8):1584-1594. doi: 10.1002/cncr.33996. Epub 2022 Feb 15. Cancer. 2022. PMID: 35167123
Atkins GT, Kim T, Munson J. Atkins GT, et al. Ann Am Thorac Soc. 2017 Mar;14(3):403-411. doi: 10.1513/AnnalsATS.201606-469OC. Ann Am Thorac Soc. 2017. PMID: 28118039
Fu C, Liu Z, Zhu F, Li S, Jiang L. Fu C, et al. Clin Respir J. 2016 May;10(3):333-41. doi: 10.1111/crj.12222. Epub 2014 Nov 26. Clin Respir J. 2016. PMID: 25307063 Review.
Slatore CG, Baumann C, Pappas M, Humphrey LL. Slatore CG, et al. Ann Am Thorac Soc. 2014 May;11(4):619-27. doi: 10.1513/AnnalsATS.201312-460OC. Ann Am Thorac Soc. 2014. PMID: 24701999 Review.
Kruse-Diehr AJ, Lewis-Thames MW, Wiedenman E, James A, Chambers L. Kruse-Diehr AJ, et al. J Rural Health. 2022 Mar;38(2):398-408. doi: 10.1111/jrh.12606. Epub 2021 Jun 18. J Rural Health. 2022. PMID: 34143906 Free PMC article.
Elliott TE, O'Connor PJ, Asche SE, Saman DM, Dehmer SP, Ekstrom HL, Allen CI, Bianco JA, Chrenka EA, Freitag LA, Harry ML, Truitt AR, Sperl-Hillen JM. Elliott TE, et al. Contemp Clin Trials. 2021 Mar;102:106271. doi: 10.1016/j.cct.2021.106271. Epub 2021 Jan 24. Contemp Clin Trials. 2021. PMID: 33503497 Free PMC article. Clinical Trial.
Megat Ramli PN, Aizuddin AN, Ahmad N, Abdul Hamid Z, Ismail KI. Megat Ramli PN, et al. Diagnostics (Basel). 2025 Jan 22;15(3):246. doi: 10.3390/diagnostics15030246. Diagnostics (Basel). 2025. PMID: 39941176 Free PMC article. Review.
Keimweiss S, Gurolnick A, Grant S, Burris J, Studts J, Lewis-Thames M. Keimweiss S, et al. J Cancer Surviv. 2025 Feb;19(1):21-34. doi: 10.1007/s11764-023-01445-7. Epub 2023 Aug 26. J Cancer Surviv. 2025. PMID: 37632652
Sofianidi A, Karadimou A, Charpidou A, Syrigos KN. Sofianidi A, et al. Cancers (Basel). 2024 Feb 23;16(5):906. doi: 10.3390/cancers16050906. Cancers (Basel). 2024. PMID: 38473268 Free PMC article. Review.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3